#4540 on the rich list of 14,452 insiders
Fuad El-Hibri
Director at Emergent BioSolutions; Director at Aptevo Therapeutics. Based in Seattle, Washington.
$23.9M
in disclosed stock, −$1.6M (−6.36%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
- Rank
- 4540th of 14,452
- Companies held
- 2
- Largest holding
- EBS, 100.0% of total
- Latest SEC filing
- Dec 3, 2021
What the $23.9M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Emergent BioSolutions EBS Common Stock | Through Yahia Fuad El-Hibri Revocable Trust | 3,018,644 | $5.15 | $15.5M | 65.1% | Form 4, Dec 3, 2021 |
| Emergent BioSolutions EBS Common Stock | Directly | 1,136,971 | $5.15 | $5.9M | 24.5% | Form 4, Dec 3, 2021 |
| Emergent BioSolutions EBS Common Stock | Through El-Hibri Family Trust | 274,930 | $5.15 | $1.4M | 5.9% | Form 4, Dec 3, 2021 |
| Emergent BioSolutions EBS Common Stock | Through El-Hibri Decedents Trust | 206,434 | $5.15 | $1.1M | 4.5% | Form 4, Dec 3, 2021 |
| Aptevo Therapeutics APVO Common Stock | Through Yahia Fuad El-Hibri Revocable Trust | 0 split-adjusted | $0.41 | $0 | 0.0% | Form 4, Dec 3, 2021 |
| Aptevo Therapeutics APVO Common Stock | Directly | 0 split-adjusted | $0.41 | $0 | 0.0% | Form 4, Dec 3, 2021 |
| Aptevo Therapeutics APVO Common Stock | Through El-Hibri Family Trust | 0 split-adjusted | $0.41 | $0 | 0.0% | Form 4, Dec 3, 2021 |
| Aptevo Therapeutics APVO Common Stock | Through El-Hibri Decedents Trust | 0 split-adjusted | $0.41 | $0 | 0.0% | Form 4, Dec 3, 2021 |
Share counts are the amounts Fuad El-Hibri reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 4537 | John S Kellington EVP, Chief Info Off. -Sub, Cincinnati Financial. Fairfield, OH | $23.9M |
| 4538 | Edward J Zander Director, Seagate Technology Holdings. Fremont, CA | $23.9M |
| 4539 | Dean A. Foate Director, Plexus. Neenah, WI | $23.9M |
| 4540 | Fuad El-Hibri Director, Emergent BioSolutions. Seattle, WA | $23.9M |
| 4541 | David Fortunato CEO and President, Wealthfront. Palo Alto, CA | $23.9M |
| 4542 | Margaret A. Horn Chief Operating Officer, Revolution Medicines. Redwood City, CA | $23.9M |
| 4543 | Prashant Aggarwal Director, Lyft. Carlsbad, CA | $23.8M |
Other Emergent BioSolutions insiders
All EBS insiders- Joseph C. Papa$2.5MPresident and CEO. #4365 overall
Questions
How much stock does Fuad El-Hibri own?
Fuad El-Hibri holds $23,880,442 in listed stock based on SEC filings and current prices, mostly Emergent BioSolutions (EBS). That ranks 4540th on the Stock Rich List.
Is this Fuad El-Hibri's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.